Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer.
Oluwalana D, Adeleye KL, Krutilina RI, Chen H, Playa H, Deng S, Parke DN, Abernathy J, Middleton L, Cullom A, Thalluri B, Ma D, Meibohm B, Miller DD, Seagroves TN, Li W.
Oluwalana D, et al. Among authors: ma d.
Cancer Lett. 2024 Jun 5:217011. doi: 10.1016/j.canlet.2024.217011. Online ahead of print.
Cancer Lett. 2024.
PMID: 38849011